{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:51:24Z","timestamp":1768200684529,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ygyno.2011.07.032","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T18:18:12Z","timestamp":1318961892000},"page":"257-262","source":"Crossref","is-referenced-by-count":12,"title":["Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia"],"prefix":"10.1016","volume":"123","author":[{"given":"Ameli","family":"Trop\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Jonassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine D.","family":"Sj\u00f8borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik A.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Cecilie","family":"Alfsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Kathrine","family":"Lie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.07.032_bb0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0015","first-page":"3097","article-title":"Large loop excision of the transformation zone for treating cervical intraepithelial neoplasia: a 12-year experience","volume":"21","author":"Paraskevaidis","year":"2001","journal-title":"Anticancer Res"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2011.07.032_bb0020","first-page":"89","article-title":"Chapter 9: clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0025","first-page":"80","article-title":"Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol","volume":"78","author":"Paraskevaidis","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1525-1438.2007.00945.x","article-title":"Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure","volume":"17","author":"Bae","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0040","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0029-7844(01)01535-6","article-title":"Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia","volume":"98","author":"Paraskevaidis","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0045","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1447-0756.2008.00989.x","article-title":"High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia","volume":"35","author":"Jeong","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0055","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses","year":"2008"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006254-200407000-00024","article-title":"HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis","volume":"59","author":"Zielinski","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-8258(03)00415-3","article-title":"HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3","volume":"91","author":"Zielinski","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2006.04.016","article-title":"Pre- and post-conization high-risk HPV testing predicts residual\/recurrent disease in patients treated for CIN 2\u20133","volume":"103","author":"Alonso","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0075","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1471-0528.2006.01063.x","article-title":"Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation","volume":"113","author":"Verguts","year":"2006","journal-title":"BJOG: Int J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0090","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.01863-08","article-title":"Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia","volume":"47","author":"Trope","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0095","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ygyno.2005.02.026","article-title":"DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia","volume":"97","author":"Lie","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2010.11.013","article-title":"HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review","volume":"120","author":"Burger","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0110","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0b013e3181891459","article-title":"HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model","volume":"28","author":"Fuste","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0125","first-page":"27","article-title":"The significance of HPV in the follow-up period after treatment for CIN","volume":"31","author":"Gallwas","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1470-2045(07)70283-8","article-title":"Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis","volume":"8","author":"Ghaem-Maghami","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0135","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.ejca.2007.05.016","article-title":"Does HPV-status 6\u201312months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?","volume":"43","author":"Strander","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","article-title":"Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study","volume":"12","author":"Kocken","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.07.032_bb0145","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811005828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811005828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T09:56:50Z","timestamp":1543485410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811005828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0090825811005828"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.07.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}